Donna Berry appointed director of the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services
Donna Berry, RN, PhD, AOCN, FAAN Donna Berry, RN, PhD, AOCN® FAAN, is the new director of the
Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute.
Berry joins Dana-Farber from the University of Washington, where she
was a professor of Biobehavioral Nursing and Health Systems and held
adjunct faculty appointments in the Departments of Urology and Medical
Education and Bioinformatics.
She also was the nurse researcher at the Seattle Cancer Care Alliance
and has held leadership positions in the Southwest Oncology Group and
the Oncology Nursing Society.
Berry will continue as principal investigator for her National
Institutes of Health-funded programs of research, evaluating her
Electronic Self-Report Assessment—Cancer program and facilitating
patient decision-making associated with prostate cancer treatment.
"Donna's programs of research in biobehavioral interventions and
quality of life position her to collaborate beautifully with our nursing
and interdisciplinary colleagues from across the Dana-Farber/Harvard
Cancer Center spectrum, and to advance the knowledge necessary to
support patients and families as they face the challenges of living with
cancer," says Patricia Reid Ponte, RN, DNSc, FAAN, NEA-BC,
Dana-Farber's senior vice president for Patient Care Services and chief
nurse.
Berry completed her undergraduate education at Baylor University. She
holds a Masters of Science in Nursing degree from the University of
Texas Health Science Center at Houston and her PhD in Nursing Science is
from the University of Washington, in Seattle.
Dana-Farber Cancer Institute (www.dana-farber.org)
is a principal teaching affiliate of the Harvard Medical School and is
among the leading cancer research and care centers in the United States.
It is a founding member of the Dana-Farber/Harvard Cancer Center
(DF/HCC), designated a comprehensive cancer center by the National
Cancer Institute.